Biologics for the Treatment of Allergic Rhinitis, Chronic Rhinosinusitis, and Nasal Polyposis
Author:
Funder
Genentech
GSK
Regeneron
University of Virginia
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference25 articles.
1. The pharmacological basis of anti-IgE therapy;Chang;Nat Biotechnol,2000
2. Clinical efficacy and safety of omalizumab in the treatment of allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials;Yu;Am J Rhinol Allergy,2019
3. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis;Casale;J Allergy Clin Immunol,2006
4. Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma;Weinstein;J Allergy Clin Immunol,2018
5. Prazma CM, Albers F, Mallett S, et al. Mepolizumab improves patient outcomes and reduces exacerbations in severe asthma patients with comorbid upper airway disease. American Academy of Asthma, Allergy, and Immunology National Meeting, San Francisco, February 22 - February 26, 2019.
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. V Brazilian Consensus on Rhinitis – 2024;Brazilian Journal of Otorhinolaryngology;2024-09
2. Blood and local eosinophil levels in chronic rhinitis: Observations during seasonal allergen exposure and non-exposure;World Allergy Organization Journal;2024-07
3. Comparison of the Efficacy of Omalizumab and Mepolizumab in Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease;International Archives of Allergy and Immunology;2024-06-12
4. Efficacy and Safety of Monoclonal Antibodies for the Treatment of Eosinophilic Esophagitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Digestive Diseases and Sciences;2024-05-06
5. A Review on Novel Therapeutic Modalities and Evidence-based Drug Treatments against Allergic Rhinitis;Current Pharmaceutical Design;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3